The effects of extracts of the aerial part of Blumea riparia DC. and their phenolic acids on hemostasis were evaluated. The EtOAc fraction showed significantly reduced blood clotting time (CT) and tail bleeding time of transection (BT) of mice in vivo. This fraction contained vanillic acid (1), syringic acid (2), p-coumaric acid (3), caffeic acid (4), and protocatechuic acid (5). Compound 1 reduced prothrombin time (PT), and strengthened mice uterine contractions. Compound 3 reduced CT and the activated partial thromboplastin time (APTT). Compound 5 reduced CT and increased the frequency of mice uterine contraction in a dose-dependent manner. Compound 2 reduced APTT. Compound 4 remarkably strengthened uterine contraction. Taken together, these data suggest that compounds 1, 3, and 5 possess procoagulant activity which jointly synergize blood coagulation via different mechanisms.
Menorrhagia and postpartum hemorrhage are common illnesses that affect many women [1a, 1b] . Oxytocin, ergot alkaloids, prostaglandins, tranexamic acid, ethamsylate, and recombinant activated factor VII are used for treatment but produce adverse reactions [1c] . Some compounds isolated from plants display hemostatic activity. For example, an extract from Blumea riparia (BL.) DC. (Compositae) is used in traditional Chinese medicine for reducing uterus blood, preventing gynecological inflammation, and accelerating body recovery postpartum. In addition, an herbal medicine produced from B. riparia DC. is clinically used for the treatment of postabortal metrorrhagia, and other gynecological problems [2a,2b] . Previous chemical studies of this plant characterized flavones, organic acids, acetylenes, and xanthene sesquiterpenes [3a-3d] , while the present study, found several additional constituents and evaluated their procoagulant activity and structure-activity relationship. Our findings provide a molecular basis for the clinical application of B.riparia in the treatment of menorrhagia and postpartum hemorrhage.
To analyze the procoagulant activity of B. riparia, the effects of orally administered fractions Fa, Fb, and Fc on blood clotting time (CT) and tail transection bleeding time (BT) in rats were examined. As shown in Table 1 , a dose of 1.08 and 2.16 g /kg Fb significantly reduced CT and BT (P<0.05), in comparison with the control group. Fa, Fb, and Fc exhibited a biphasic effect on the blood coagulation, by which the CT and BT increased at a dose of 4.32 g /kg. Similarly, polysaccharides from green seaweeds also showed a dual hemostatic effect, that is, inhibition or activation of coagulation pathways at different doses [4a] . These results give a scientific explanation for the folkloric use of B. riparia as a hemostatic in gynecology, as well as an inhibitor of thrombus formation at larger doses.
As Fb exhibited better hemostatic activity than the other fractions, it was fractionated to give the five phenolic acids, vanillic (1), syringic (2), p-coumaric (3), caffeic (4), and protocatechuic (5). The hemostatic activities of these compounds were examined by CT, prothrombin time (PT) and activated partial thromboplastin time (APTT), and uterine contractility, which are commonly used for evaluating hemostatic agents. As large amounts NPC Natural Product Communications 2010 Vol. 5 No. 8 1263 -1266 of test samples were required for the week-long daily oral administration, sufficient quantities of compounds 1-5 had to be purchased. Interestingly, at a dose of 3 mmol/kg, only compound 3 ( Figure 1 ) significantly decreased CT (P <0.05), suggesting that, while compound 3 may be effective, other procoagulant components may be present to account for the high dose of compound 3 needed.
Blood coagulation results from a series of proteolytic reactions involving the step-wise activation of coagulation factors I-XII. Subsets of these factors can be activated by two distinct pathways, the extrinsic and the intrinsic pathway.
[4b] The APTT is commonly used for determining the overall efficiency of the intrinsic coagulation pathway, while PT is the screening test for the extrinsic coagulation pathway [4c]. The APTT was reduced to12.5, 13.3, and 15.6% in mice treated with compounds 2, 3, and 5 when compared to the control group. However, the PT values remained unchanged in the presence or absence of these compounds (Table 2) . These data suggest that the intrinsic coagulation pathway may be the target of these compounds. Protocatechuic acid (5) can enhance the activity of anticoagulant factors such as antithrombin-III and protein C [4d].. This observation may be explained if it has dual functions in the coagulation system. It may act as a procoagulant to promote thrombus when bleeding occurs and also act as an anticoagulant when combined with the cofactor thrombomodulin in the protein case complex [5a, 5b] .
Vanillic acid (1) significantly lowered PT, but had no effect on APTT. The lessening of PT suggested that 1 could activate the extrinsic coagulation pathway. A similar observation showed that 1 had weak antithrombotic effects when evaluated for thrombosis in the mice model [6a] . It also decreased the recalcification time in a dose-dependent manner and inhibited 5'nucleotidase activity specifically, which mediated the The effects of different phenolic acids on spontaneous contractile activity of uterine smooth muscle in estrous mice were compared. As summarized in Table 3 , there was no obvious difference in the tension of uterine contraction before and after the addition of phenolic acids to the bath, except for compounds 2 and 4. Surprisingly, compounds 4 and 5 significantly increased the frequency of uterine contraction in a dose-dependent manner (P < 0.01). Compound 1 also accelerated the frequency of uterine contraction at 1.43×10 -4 mmol/ml (P < 0.05). These results indicate that phenolic acids can strengthen the frequency of mice uterine contractions, while only affecting tension slightly. Alteration of uterine contractions by drugs is important in obstetrics practice. Inadequate uterine contractions could impede labor and increase the incidence of emergency caesarian sections, whereas promotion of uterine contractions could prevent or treat excessive hemorrhage in the immediate postpartum period [7] . Based on the above it may be assumed that 4 and 5 strengthen contraction of uterine and blood vessel to promote the repair and Pro-coagulant activity of phenolic acids Natural Product Communications Vol. 5 (8) 2010 1265 Negative control, saline solution; positive control, oxytocin and dose is 1×10 -3 unit/mL.Values are mean±S.D. (n = 8). The uterine contractions were recorded for 10 min immediately before and after addition of phenolic acids to the bath. *Contraction after addition of phenolic acids is significantly different from the values before its addition to the organ bath at p <0.05 using paired ttest with a two-tailed p-value. **Contraction after addition of phenolic acids is significantly different from the values before its addition to the organ bath at p <0.01 using paired sample t-test with a two-tailed p-value.
regeneration of tissue, thus preventing hemorrhage. B. riparia DC. can therefore not only be used for postpartum care, but also for treating irregular, painful, or excessive menstruation, uterine pain and dysfunction.
Experimental
General: The ethanol extract of B. riparia DC. was provided by Guixi Pharmacy Co., Ltd. of Naning, Guangxi, China. Caffeic acid (4) was purchased from Shanghai Junchuang Biological Tech. co., (Shanghai, China) . p-Coumaric acid (3), vanillic acid (1), syringic acid (2) and protocatechuic acid (5) 
Extraction and sample preparations:
The ethanol extract of (4.5 kg) B. riparia. was evaporated under reduced pressure to obtain a residue (3.2 kg), which was diluted with water (6.4 kg) and extracted several times with petroleum ether. The petroleum ether extracts were combined to form fraction (Fa). The aqueous layer was further extracted with EtOAc to give fraction (Fb) and the residual aqueous layer gave fraction (Fc). All these fractions were evaporated under reduced pressure to give dried products, Fa (142.7 g), Fb (286.7 g), and Fc (2520 g).
Among the extracts and fractions tested for their procoagulant activities (Table 1) , Fb showed significant inhibition activities. Fb (100 g) was repeatedly chromatographed over a silica-gel to give vanillic acid (1) (14 mg) and syringic acid (2) (18 mg), p-coumaric acid (3) (22 mg), caffeic acid (4) (54 mg) and protocatechuic acid (5) (36 mg). These phenolic acids were identified by comparison of physical and spectroscopic data with literature data. [8a-8d] Animals: Mice (Kingming strain) weighing 18-22 g were used to assay CT and BT in vivo. Female mice (Kingming strain) weighing 25-30 g were used to assay uterine contractility. New Zealand rabbits weighing 1.8-2.2 kg were used to assay PT and APTT in vivo.
The animal experiments were conducted in accordance with international guidelines.
Assay of blood clotting time in vivo (CT):
The blood clotting time was evaluated by the glass slide method [9a] . The fractions (Fa, Fb, and Fc) and phenolic acids were dissolved in water. Experimental mice were divided into 25 groups of 8 and administrated with the fractions or reagents at 0.1ml/10g by an oral gavage with a syringe. The control groups were treated with saline solution. The positive groups were injected with ethamsylate (Beijing Pharmaceutical Factory, Beijing, China) at 0.25g/kg. After three days, each mouse's inner canthus was punctured with a glass capillary and a drop of blood from the supraorbital vein was collected on a glass slide. The bleeding time was recorded between blood collection and blood streak formation.
Tail transection bleeding time in vivo (BT):
Experimental mice were divided into 11 groups each consisting of 8 mice. The preparations of the fractions, control group, positive groups and the manner of administration are similar to that described above for the CT assay. After three days, the mice were anesthetized with sodium pentobarbital. The bleeding time was recorded according to the method by Dejana et al. [9b] .
Assay for prothrombin time (PT) and activated partial thromboplastin time (APTT) in vivo:
Experimental rabbits were divided into 8 groups of 3 and 10 ml/kg of the reagent administered with a syringe by an oral gavage for once a day for three days at the same time. The positive groups were given 1g/kg Yunnan white power (Yunnan Baiyao Group Co., Ltd., Yunnan, China). Rabbit blood was collected with plastic disposable syringes 1h after the rabbits were administered in the third day. Fresh blood was mixed with 1:9 volume of 3.2% sodium citrate. Platelet poor plasma was obtained by centrifuging citrated blood for 15 min at 3000 × g. PT and APTT were determined immediately using a kit according to the cited method 1266 Natural Product Communications Vol. 5 (8) 2010
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[9c] All experiments were carried out in at least duplicates.
Measurement of uterine contractility in vitro:
Female mice were injected subcutaneously with 0.1mg/kg estradiol (Mingxin Pharmaceutical Co., Ltd., Guangzhou, China). After two days, the mice were sacrificed by decapitation. Both uterine horns were isolated, cut in half, and placed in isolated organ baths incubated with De Jalon's solution bubbled with carbogen mixture (95% O 2 and 5% CO 2 ) at 37±0.5ºC. Each uterine horn was subjected to a resting tension of 0.5-1g and equilibrated for at least 30-45 min before the reagents were added to the organ baths. The positive groups were treated with oxytocin 1×10 -3 unit/mL. The mice uterus contractions were recorded by polygraph system (HW-400S) (Chengdu, China.) [9d].
Statistical analysis: Data are expressed as mean±SD(standard deviations), and statistical significance was determined by one-way analysis of variance (ANOVA) and Tukey's test. In the measurement of uterine contractility, the differences between before and after addition of samples were tested for paired t-test with a two-tailed p-value. A value of p<0.05 was considered significant.
